Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload

被引:3
|
作者
Kiguchi, Toru [1 ]
Ito, Yoshikazu [1 ]
Kimura, Yukihiko [1 ]
Ohyashiki, Kazuma [1 ]
机构
[1] Tokyo Med Univ, Div Hematol, Dept Internal Med 1, Shinjuku Ku, Tokyo 1600023, Japan
关键词
MAGNETIC-RESONANCE;
D O I
10.1007/s12185-009-0310-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:546 / 548
页数:3
相关论文
共 50 条
  • [31] Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil
    Wood, John C.
    Otto-Duessel, Maya
    Gonzalez, Ignacio
    Aguilar, Michelle I.
    Shimada, Hiro
    Nick, Hanspeter
    Nelson, Marvin
    Moats, Rex
    TRANSLATIONAL RESEARCH, 2006, 148 (05) : 272 - 280
  • [32] Iron chelation effect of curcumin and baicalein on aplastic anemia mouse model with iron overload
    Wu Dijiong
    Wen Xiaowen
    Xu Linlong
    Liu Wenbin
    Hu Huijin
    Ye Baodong
    Zhou Yuhong
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 22 (06) : 660 - 668
  • [33] A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients
    E. Cassinerio
    A. Roghi
    N. Orofino
    P. Pedrotti
    L. Zanaboni
    E. Poggiali
    M. Giuditta
    D. Consonni
    M. D. Cappellini
    Annals of Hematology, 2015, 94 : 939 - 945
  • [34] Iron Chelation Therapy with Deferasirox Results in Recovery of Hematopoiesis in a Child with Aplastic Anemia
    Lee, Jae Wook
    Jang, Pil-Sang
    Chung, Nack-Gyun
    Cho, Bin
    Jeong, Dae-Chul
    Kim, Hack-Ki
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (08) : 718 - 720
  • [35] A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients
    Cassinerio, E.
    Roghi, A.
    Orofino, N.
    Pedrotti, P.
    Zanaboni, L.
    Poggiali, E.
    Giuditta, M.
    Consonni, D.
    Cappellini, M. D.
    ANNALS OF HEMATOLOGY, 2015, 94 (06) : 939 - 945
  • [36] Improvement in Hematopoiesis after Iron Chelation Therapy with Deferasirox in Patients with Aplastic Anemia
    Lee, Sung-Eun
    Yahng, Seung-Ah
    Cho, Byung-Sik
    Eom, Ki-Sung
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Kim, Hee-Je
    Cho, Seok-Goo
    Kim, Dong-Wook
    Min, Woo-Sung
    Park, Chong-Won
    Lee, Jong Wook
    ACTA HAEMATOLOGICA, 2013, 129 (02) : 72 - 77
  • [37] A 5-Years Follow-up in Deferasirox Treatment: Improvement of Cardiac and Hepatic Iron Overload and Amelioration in Cardiac Function in Thalassemia Major Patients
    Cassinerio, Elena
    Roghi, Alberto
    Orofino, Nicola
    Pedrotti, Patrizia
    Zanaboni, Laura
    Poggiali, Erika
    Giuditta, Marianna
    Consonni, Dario
    Cappellini, Maria Domenica
    BLOOD, 2014, 124 (21)
  • [38] Iron overload and cardiac adrenergic innervation
    Koutelou, M
    Adamopoulos, S
    Georgiadis, M
    Flevari, P
    Livanis, EG
    Hatzilaou, J
    Mavrogeni, S
    Kremastinos, DT
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1075 - 1075
  • [39] Iron overload in patients with MDS: Baseline data from studies of the once-daily oral iron chelator, deferasirox
    Baer, R.
    Esposito, J.
    Kang, B.
    Virkus, J.
    Paley, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 379 - 380
  • [40] Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study)
    Ho, P. Joy
    Tay, Lay
    Teo, Juliana
    Marlton, Paula
    Grigg, Andrew
    St Pierre, Tim
    Brown, Greg
    Badcock, Caro-Anne
    Traficante, Robert
    Gervasio, Othon L.
    Bowden, Donald K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (02) : 97 - 105